Experienced in Factor 12 Deficiency

Dr. Robert C. Bernstein

Advanced Heart Failure and Transplant Cardiology | Cardiology | Cardiac Electrophysiology
Sentara Medical Group
844 Kempsville Rd, Suite 204, 
Norfolk, VA 
Accepting New Patients
Offers Telehealth
Experienced in Factor 12 Deficiency
Sentara Medical Group
844 Kempsville Rd, Suite 204, 
Norfolk, VA 
OverviewInsuranceLocationsClinical Research

Overview

Robert Bernstein is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Norfolk, Virginia. Dr. Bernstein is rated as an Experienced provider by MediFind in the treatment of Factor 12 Deficiency. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Arrhythmias, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Pacemaker Implantation, and Cardiac Ablation. Dr. Bernstein is currently accepting new patients.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Advanced Heart Failure and Transplant Cardiology
Cardiology
Cardiac Electrophysiology
Licenses
Internal Medicine in VA
Hospital Affiliations
Sentara Leigh Hospital
Sentara Norfolk General Hospital
Sentara Virginia Beach General Hospital
Sentara Princess Anne Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthKeepers
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Optima Health
  • HMO
  • POS
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Virginia Premier Health Plan
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

SENTARA MEDICAL GROUP
844 Kempsville Rd, Suite 204, Norfolk, VA 23502

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Multi-Centre, Open-Label, Safety Study of Etripamil Nasal Spray in Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia The NODE-302 Trial (Extension of NODE-301)
Multi-Centre, Open-Label, Safety Study of Etripamil Nasal Spray in Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia The NODE-302 Trial (Extension of NODE-301)
Enrollment Status: Terminated
Publish Date: November 05, 2024
Intervention Type: Drug, Device
Study Phase: Phase 3
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Enrollment Status: Terminated
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drug: Etripamil
Study Phase: Phase 3
Multi-Center, Placebo-Controlled, Dose-Ranging Phase 2 Electrophysiological Study of Intranasal Administration of MSP-2017 for the Conversion of Induced Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm
Multi-Center, Placebo-Controlled, Dose-Ranging Phase 2 Electrophysiological Study of Intranasal Administration of MSP-2017 for the Conversion of Induced Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm
Enrollment Status: Completed
Publish Date: December 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

3 Total Publications

Safety of magnetic resonance imaging scanning in patients with cardiac resynchronization therapy-defibrillators incorporating quadripolar left ventricular leads.
Safety of magnetic resonance imaging scanning in patients with cardiac resynchronization therapy-defibrillators incorporating quadripolar left ventricular leads.
Journal: Heart rhythm
Published: March 05, 2020

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bernstein's expertise for a condition
ConditionClose
    View All 17 Distinguished Conditions
    View All 36 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile